ORLANDO, Fla., Oct. 3, 2019 /PRNewswire/ — Therigy®, the trusted partner for specialty pharmacy management software and services, is excited to announce the launch of mobile-enabled patient assessments via Therigy’s flagship SaaS platform, TherigySTM™. This advanced patient engagement enables pharmacies to deliver customized assessments directly to patients via their mobile device to answer when it is convenient for them. The result is pharmacies reach patients faster – often avoiding several days of delay from call attempts – and more effectively engaging with patients. Improving patient adherence is challenging and although various intervention strategies have been used, the use of mobile messaging has been proven to be most effective according to a recent JAMA study1 which demonstrated text message interventions had high acceptance rates and increased patient adherence by 17.8%.
“We are very excited to launch our mobile-enabled patient assessments capability within TherigySTM,” states Joe Morse, Chief Executive Officer, Therigy. “This tool enables our customers to improve the lives of their patients through greater education, support and interventions, ultimately improving adherence and demonstrating outcomes.”
For more information on Therigy’s mobile-enabled patient assessments within TherigySTM or to get started now, please visit: https://www.therigy.com/mobile-enabled-patient-assessments
1. Source: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2484905
Therigy® is a patient-focused specialty therapy management company. As an industry pioneer, Therigy continues to lead the specialty pharmacy market serving over one million active patients and eight thousand subscribers nationwide. Therigy equips pharmacy stakeholders with the tools to standardize and scale patient management programs—with a depth and consistency of clinical care never before possible—helping them to grow their patient population, deliver value-based outcomes, gain insights into evolving patient needs, and predict therapy trends. Learn more about Therigy at www.therigy.com.
Media Contact:
Lindsey Harris
407.992.8750
lindsey.harris@therigy.com
Related Images
therigy.jpg
Therigy
View original content to download multimedia:http://www.prnewswire.com/news-releases/therigy-announces-mobile-enabled-patient-assessments-to-improve-adherence-300930808.html
SOURCE Therigy
Dr. Ran Rubinstein discusses how individualized treatment planning determines when fillers, neurotoxins, or collagen-stimulating injectables…
PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the…
TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the…
Melbourne, Australia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Key Highlights from the Quarter ACCENT Trial…
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX…
Company expects up to six-month review period per FDA guidelines New longer-term clinical data demonstrating…